(Q44818140)

6 December 2017

Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control study (English)

1 reference

polycystic ovary syndrome

6 December 2017

1 reference

1 reference

1 reference

coronary artery disease

1 reference

1

1 reference

6 December 2017

Clerici A

2

1 reference

6 December 2017

Berga SL

3

1 reference

6 December 2017

Kuller L

4

1 reference

6 December 2017

Guzick D

5

1 reference

6 December 2017

Detre K

6

1 reference

6 December 2017

Daniels T

7

1 reference

6 December 2017

Engberg RA

8

1 reference

6 December 2017

1 May 1998

1 reference

6 December 2017

8

1 reference

Journal of Clinical Epidemiology

inferred from page(s)

published in

1 reference

6 December 2017

51

1 reference

6 December 2017

5

1 reference

6 December 2017

415-422

1 reference

Lipid metabolism in women with polycystic ovary syndrome: possible implications for an increased risk of coronary heart disease

6 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2898%2900010-9

7 January 2021

Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2898%2900010-9

7 January 2021

Insulin resistance in nonobese patients with polycystic ovarian disease

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2898%2900010-9

7 January 2021

Characterization of Hyperandrogenism with Insulin-Resistant Diabetes Type A

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2898%2900010-9

7 January 2021

Insulin and C-peptide levels in obese patients with polycystic ovaries

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2898%2900010-9

7 January 2021

The role of hyperinsulinemia in the development of lipid disturbances in nonobese and obese women with the polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2898%2900010-9

7 January 2021

Lipoprotein abnormalities in hirsute women. II. Compensatory responses of insulin resistance and dehydroepiandrosterone sulfate with obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2898%2900010-9

7 January 2021

Lipid and apolipoprotein abnormalities in hirsute women. I. The association with insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2898%2900010-9

7 January 2021

Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2898%2900010-9

7 January 2021

Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2898%2900010-9

7 January 2021

Hereditary factors in the Stein-Leventhal syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2898%2900010-9

7 January 2021

Coronary heart disease risk factors in women with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2898%2900010-9

7 January 2021

Polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2898%2900010-9

7 January 2021

Primary prevention of coronary heart disease in women

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2898%2900010-9

7 January 2021

Relationship of endogenous sex steroid hormones to lipids and apoproteins in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2898%2900010-9

7 January 2021

Insulin resistance, compensatory hyperinsulinaemia, and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2898%2900010-9

7 January 2021

Carotid atherosclerosis in women with polycystic ovary syndrome: initial results from a case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2898%2900010-9

7 January 2021

10.1016/S0895-4356(98)00010-9

Identifiers

DOI

1 reference

6 December 2017

1 reference